- Diagnostics
- Wednesday, 25 Mar 2020
Novacyt and Yourgene Healthcare companies to produce coronavirus test products in UK
Healthcare companies Novacyt and Yourgene Health Plc said on Wednesday that they would be teaming up to produce coronavirus testing products in the United Kingdom.
Yourgene’s manufacturing facility in Manchester will be used to expand Novacyt’s production capacity of the COVID-19 test.
The first batches of the critical components are expected to be shipped from the Manchester site to Novacyt’s Primerdesign unit in Southampton over the next few weeks.
“As the global demand for our COVID-19 test continues to increase, we are pleased to have rapidly established a relationship with the expert team at Yourgene to further expand our manufacturing capacity,” Novacyt CEO Graham Mullis said.
Related Industry Updates
Rochester RHIO Turns to eHealth Technologies to Deliver Solutions for 3D Image Sharing
Mar 06, 2020
Asia Pacific Companion Animal Diagnostics Market Research Along With COVID-19 Impact Analysis, Advancement and Outlook 2027| Fujifilm Corporation, Skyla Corporation, Virbac
Nov 30, 2020
Allergy Diagnostics Market - SWOT Analysis of Major Industry Segments
Dec 19, 2020
$4.6m Awarded for Clinical Trials at Northwell's Cancer Institute
Oct 16, 2019
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Nov 11, 2019
Allergy Treatment Progress in Regeneron’s Immunology Pipeline
Feb 11, 2026
Europe Surety Market to Witness an Outstanding Growth During 2020 With Top Key Players are CNA Financial Corporation,The Travelers Indemnity Company,Liberty Mutual Insurance Company,Chubb
Oct 26, 2020
Follow us on
